Tolerability of meropenem in children with IgE-mediated hypersensitivity to penicillins

Allergy
Marina Atanasković-MarkovićA Romano

Abstract

Administration of meropenem to penicillin-allergic patients who might benefit from this treatment is usually avoided because of a 47.4% rate of cross-reactivity to imipenem, the prototype of the carbapenem class of beta-lactam antibiotics, demonstrated in a single study on the basis of positive responses to skin tests with imipenem reagents. However, recent studies of ours have demonstrated a very low rate of cross-reactivity between penicillins and both meropenem and imipenem in adults. To assess cross-reactivity and tolerability of meropenem in children with documented penicillin allergy. One hundred and eight consecutive children who had suffered a total of 129 immediate reactions (120 urticarial and/or angioedematous manifestations and 9 anaphylactic shocks) to penicillins and had positive results to skin tests for at least one of the penicillin reagents tested underwent skin tests with meropenem and negative subjects were challenged with it. One subject (0.9%) displayed a positive intradermal test to meropenem. The remaining 107 subjects with negative skin tests to meropenem tolerated challenges. Challenges were not followed by full therapeutic courses. Our results demonstrate a low rate of cross-reactivity between penicil...Continue Reading

References

Aug 1, 1988·The Journal of Allergy and Clinical Immunology·A SaxonG B Calandra
Apr 30, 1999·International Journal of Antimicrobial Agents·J S BradleyJ P Quinn
Jan 1, 1996·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Oana CiofuNiels Høiby
Sep 27, 2003·Allergy·M J TorresUNKNOWN EAACI Interest Group on Drug Hypersensitivity
Apr 20, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·William A PrescottRandolph E Regal
Jul 9, 2004·Annals of Internal Medicine·Antonino RomanoJean-Louis Guéant
Oct 16, 2004·The Journal of Antimicrobial Chemotherapy·Manica SodhiRaja Shekar
Jun 30, 2006·The New England Journal of Medicine·Antonino RomanoJean-Louis Guéant
Feb 21, 2007·Annals of Internal Medicine·Antonino RomanoJean-Louis Guéant

❮ Previous
Next ❯

Citations

Mar 1, 2011·Annales Françaises D'anesthèsie Et De Rèanimation·F LavaudC Ponvert
Mar 7, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ying-Fang LinWen-Hung Chung
Jul 23, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brittany KulaJoan L Robinson
Jul 16, 2014·The Journal of Allergy and Clinical Immunology. in Practice·Kimberly G BlumenthalAleena Banerji
Feb 26, 2014·The Journal of Allergy and Clinical Immunology. in Practice·Antonino Romano, Jean-Christoph Caubet
Dec 3, 2014·Immunology and Allergy Clinics of North America·John M Kelso
Jan 10, 2012·Expert Opinion on Drug Safety·Philippe Lagacé-Wiens, Ethan Rubinstein
Apr 29, 2014·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Michael E Pichichero, Robert Zagursky
Feb 24, 2016·Current Allergy and Asthma Reports·Antonino RomanoRocco Luigi Valluzzi
Jul 9, 2013·Critical Care Clinics·Wendy I Sligl, Thomas J Marrie
Jan 31, 2009·Allergy·P-J BousquetA Romano
Jul 22, 2008·Pharmacoepidemiology and Drug Safety
Aug 5, 2011·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M J TorresM Blanca
Dec 3, 2014·The Journal of Allergy and Clinical Immunology·Francesco GaetaAntonino Romano
May 24, 2016·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Esther A KingLeonard Bielory
Jul 16, 2016·Expert Review of Clinical Pharmacology·Marina Atanaskovic-Markovic, Jean-Christoph Caubet
Apr 4, 2017·The Journal of Allergy and Clinical Immunology. in Practice·Eric MacyDavid Khan
Jul 6, 2017·International Journal of Molecular Sciences·Ozge SoyerBulent Enis Sekerel
Feb 6, 2009·The Annals of Pharmacotherapy·Jane Frumin, Jason C Gallagher
Apr 2, 2010·Allergy, Asthma & Immunology Research·Bernard Yu-Hor Thong
Mar 4, 2017·The British Journal of Dermatology·N R AdlerE J Phillips
May 23, 2014·Current Opinion in Allergy and Clinical Immunology·Tahia D FernandezMaria J Torres
Jun 11, 2011·Current Opinion in Allergy and Clinical Immunology·Ticha RerkpattanapipatPascal Demoly
Dec 24, 2010·Journal of Clinical Pathology·Andrew McLean-TookeGavin P Spickett
Sep 21, 2011·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Marina Atanasković-Marković
Nov 7, 2019·Current Pharmaceutical Design·Aslı GelincikSemanur Kuyucu
Jan 28, 2021·Journal of Asthma and Allergy·Cristiano CarusoAntonino Romano
Oct 12, 2020·The Journal of Allergy and Clinical Immunology. in Practice·Ana Dioun BroylesMariana Castells
Nov 12, 2021·The Journal of Medical Investigation : JMI·Haruna IwazawaShinji Kosaka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.